Latest Insider Transactions at Atri Cure, Inc. (ATRC)
This section provides a real-time view of insider transactions for Atri Cure, Inc. (ATRC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AtriCure, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AtriCure, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+1.4%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
547
+0.97%
|
$20,786
$38.11 P/Share
|
|
Jun 30
2023
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
557
+0.09%
|
$21,166
$38.11 P/Share
|
|
Jun 30
2023
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
557
+1.55%
|
$21,166
$38.11 P/Share
|
|
Jun 08
2023
|
Karen Prange Director |
SELL
Open market or private sale
|
Direct |
713
-4.23%
|
$33,511
$47.89 P/Share
|
|
Jun 06
2023
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,422
-3.92%
|
$66,834
$47.03 P/Share
|
|
Jun 01
2023
|
Deborah Lee Yount Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,589
-5.4%
|
$116,505
$45.78 P/Share
|
|
May 31
2023
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
1,000
-0.17%
|
-
|
|
May 26
2023
|
Maggie Yuen Director |
SELL
Open market or private sale
|
Direct |
4,313
-47.95%
|
$202,711
$47.04 P/Share
|
|
May 25
2023
|
Robert S. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+3.88%
|
-
|
|
May 25
2023
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+15.9%
|
-
|
|
May 25
2023
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+26.16%
|
-
|
|
May 25
2023
|
Sven Wehrwein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+13.07%
|
-
|
|
May 25
2023
|
B Kristine Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+8.0%
|
-
|
|
May 25
2023
|
Regina E Groves Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+12.18%
|
-
|
|
May 25
2023
|
Maggie Yuen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,186
+26.16%
|
-
|
|
May 01
2023
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,417
-10.84%
|
$194,348
$44.83 P/Share
|
|
Mar 13
2023
|
Mark A Collar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.02%
|
$90,000
$9.3 P/Share
|
|
Mar 01
2023
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,239
+29.37%
|
-
|
|
Mar 01
2023
|
Douglas J Seith Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,687
-9.57%
|
$444,106
$38.81 P/Share
|
|
Mar 01
2023
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,507
+16.06%
|
-
|
|
Mar 01
2023
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,894
-14.47%
|
$261,972
$38.81 P/Share
|
|
Mar 01
2023
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,140
+22.79%
|
-
|
|
Mar 01
2023
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
1,600
-0.13%
|
-
|
|
Mar 01
2023
|
Michael H Carrel President, CEO, & Director |
SELL
Payment of exercise price or tax liability
|
Direct |
45,470
-7.06%
|
$1,727,860
$38.81 P/Share
|
|
Mar 01
2023
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
115,227
+8.52%
|
-
|
|
Mar 01
2023
|
Salvatore Privitera Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,314
-7.43%
|
$239,932
$38.81 P/Share
|
|
Mar 01
2023
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,140
+13.19%
|
-
|
|
Mar 01
2023
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,793
-11.01%
|
$182,134
$38.81 P/Share
|
|
Mar 01
2023
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,140
+24.82%
|
-
|
|
Mar 01
2023
|
Angela L Wirick Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,532
-3.71%
|
$134,216
$38.81 P/Share
|
|
Mar 01
2023
|
Angela L Wirick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,478
+20.43%
|
-
|
|
Mar 01
2023
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,083
-11.32%
|
$269,154
$38.81 P/Share
|
|
Mar 01
2023
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,140
+17.61%
|
-
|
|
Feb 27
2023
|
Robert S. White Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+20.88%
|
$160,000
$8.48 P/Share
|
|
Dec 30
2022
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
294
+1.68%
|
$9,996
$34.86 P/Share
|
|
Dec 30
2022
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
585
+1.5%
|
$19,890
$34.86 P/Share
|
|
Dec 30
2022
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
609
+0.76%
|
$20,706
$34.86 P/Share
|
|
Nov 17
2022
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
6,000
-1.12%
|
-
|
|
Sep 15
2022
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,983
-20.43%
|
$224,235
$45.99 P/Share
|
|
Aug 31
2022
|
Robert S. White Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.19%
|
$120,000
$8.48 P/Share
|
|
Aug 06
2022
|
Angela L Wirick Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,191
-6.83%
|
$259,550
$50.94 P/Share
|
|
Jun 30
2022
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+1.47%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+1.41%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+0.57%
|
$11,900
$34.73 P/Share
|
|
Jun 30
2022
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
350
+0.07%
|
$11,900
$34.73 P/Share
|
|
Jun 01
2022
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,900
+50.0%
|
-
|
|
May 25
2022
|
Mark A Collar Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+3.77%
|
-
|
|
May 25
2022
|
Deborah H Telman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+38.02%
|
-
|
|
May 25
2022
|
Karen Prange Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+20.68%
|
-
|